Skip to content

Clinical trials

Coronary Artery Disease trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Artery Disease Country / region: United States Clear all

1,089 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20008
20017
200219
200322
200423
200526
200660
200759
200855
200976
201067
201150
201260
201360
201451
201553
201644
201737
201847
201940
202025
202131
202224
202329
202435
202530
202626

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed718
Terminated106
Unknown status72
Recruiting66
Active, not recruiting46
Withdrawn44
Not yet recruiting21
Enrolling by invitation10
Suspended6

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Abbott Medical Devices43
University of Florida39
National Heart, Lung, and Blood Institute (NHLBI)33
Boston Scientific Corporation27
Emory University24
Mayo Clinic22
Johns Hopkins University20
Brigham and Women's Hospital17
Icahn School of Medicine at Mount Sinai17
Massachusetts General Hospital16

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Artery Disease1,089
Cardiovascular Diseases97
Coronary Disease94
Myocardial Ischemia89
Atherosclerosis88
Heart Diseases86
Myocardial Infarction86
Diabetes Mellitus62
Chest Pain52
Angina Pectoris50

Trials

Showing 26 to 50 of 1,089. Each trial links to its page on Pharma Observatory.

989 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.